Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms (2016)
- Authors:
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- DOI: 10.1186/s13000-016-0476-4
- Subjects: LEUCEMIA MIELOIDE AGUDA; BIOMARCADORES; PROTEÍNAS PROTO-ONCOGÊNICAS
- Keywords: Ten-eleven-translocation 2; TET2; Mutation; Myelodysplastic syndromes; Acute myeloid leukemia
- Language: Inglês
- Imprenta:
- Source:
- Título: Diagnostic Pathology
- ISSN: 1746-1596
- Volume/Número/Paginação/Ano: v. 11, n.1, art. 28, 2016
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SCOPIM-RIBEIRO, Renata et al. Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms. Diagnostic Pathology, v. 11, n. 1, 2016Tradução . . Disponível em: https://doi.org/10.1186/s13000-016-0476-4. Acesso em: 24 fev. 2026. -
APA
Scopim-Ribeiro, R., Machado Neto, J. A., Campos, P. de M., Niemann, F. S., Lorand-Metze, I., Costa, F. F., et al. (2016). Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms. Diagnostic Pathology, 11( 1). doi:10.1186/s13000-016-0476-4 -
NLM
Scopim-Ribeiro R, Machado Neto JA, Campos P de M, Niemann FS, Lorand-Metze I, Costa FF, Saad STO, Traina F. Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms [Internet]. Diagnostic Pathology. 2016 ; 11( 1):[citado 2026 fev. 24 ] Available from: https://doi.org/10.1186/s13000-016-0476-4 -
Vancouver
Scopim-Ribeiro R, Machado Neto JA, Campos P de M, Niemann FS, Lorand-Metze I, Costa FF, Saad STO, Traina F. Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms [Internet]. Diagnostic Pathology. 2016 ; 11( 1):[citado 2026 fev. 24 ] Available from: https://doi.org/10.1186/s13000-016-0476-4 - Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412
- FMNL1 promotes proliferation and migration of leukemia cells
- SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype
- IRS1 (insulin receptor substrate 1)
- Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia
- IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients
- Hedgehog pathway is deregulated in myelodysplastic syndrome progenitor bone marrow cells
- Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome
Informações sobre o DOI: 10.1186/s13000-016-0476-4 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
